Zdrowie i gospodarka · 30/01/2020

FDA Releases Draft Guidance on Gene Therapy Products for Orphan Drug Designation

The FDA has released a draft guidance document outlining its criteria for determining sameness of human gene therapy products to aid in the development of gene therapies for rare diseases, in line with the agency's orphan drug regulations.